Delivery Order SPE2DB20D7066-SPE2DB26FC1MQ
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Thrombin-JMI 5,000 unit vials. This competitively awarded, non-set-aside contract carries a ceiling value of $7,615.26 under a firm fixed-price delivery order arrangement, with an ultimate completion date of September 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,895.82 on August 26, 2025, for the supply of Thrombin-JMI 5,000 units vials, with an ultimate completion date of August 27, 2025. This firm fixed price contract is non-competitive and non-set-aside, with performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The award is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,236.16 firm fixed-price contract is for the supply of 4,557,711,596 units of Thrombin-JMI, a 20,000-unit vial medication. The award was made on July 5, 2022, with a completion date of July 6, 2022. This contract is a task order under AmerisourceBergen's larger $999,999,999 Indefinite...
- This federal contract award, valued at $5,928.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 contract vehicle that enables efficient procurement of essential pharmaceutical and medical supplies for military healthcare programs globally. The contract covers the...
- This federal contract award, valued at $14,329.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20,000 unit vials of THROMBIN-JMI, a medical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award is for the delivery of 5,000-unit vials of Thrombin-JMI, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,872.51, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on August 30, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 3, 2024. This award is not associated with a set-aside program. As...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,221.58 Firm Fixed Price delivery order covers the supply of 20,000 unit vials of Thrombin-JMI, a critical medication. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (parent company of Amerisourcebergen Drug Corp) holds with the DLA...
- This federal contract award is for the delivery of THROMBIN-JMI 20,000 UNITS VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 1, 2021, with a ceiling value of $13,799.82 and a completion date of September 2, 2021. The contract is a Delivery Order under a Firm Fixed Price contract type. Amerisourcebergen Drug Corp is a subsidiary of the...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of 5,000 unit vials of Thrombin-JMI, a specialty pharmaceutical product, with a potential value of $1,615.50. The contract has a completion date of March 6, 2024 and was awarded on March 5, 2024. No set-aside designation was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical procedures. This firm fixed-price delivery order, valued at $4,839.49, represents a competitive award with no set-aside designation and is scheduled for completion by August 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB26FC1MQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Thrombin-JMI 20,000 unit vials valued at $1,550.51. This firm fixed-price delivery order, with an ultimate completion date of October 31, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026. The award was made without a set-aside designation through competitive procurement, and performance will be completed at the company's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor in the federal medical supply chain, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contracts with the DLA demonstrates its capability to fulfill diverse pharmaceutical procurement requirements, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This specific delivery order for thrombin, a critical hemostatic agent used in surgical and medical applications, exemplifies the company's role in supporting Defense Health Agency and other federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/30/25 |